97355 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
New Interleukin-7 Immunoconjugates
#2IL-18 POLYPEPTIDES FUSED TO IMMUNE CELL ANTIGEN SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF
#3THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR
#4METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS
#5INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE
#6ARTIFICIAL SYNAPSES
#7COMPOSITIONS AND METHODS OF TREATING TISSUE DAMAGE
#8NKp46-Binding Polypeptides and Uses Thereof
#9DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE
#10Bispecific FC Fusion Proteins with sPD-1 and IL-15
#11FUSION MOLECULES AND IL-15 VARIANTS
#12Anti-pd-1 antibody-attenuated IL-2 immunoconjugates and uses thereof
#13SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL DELIVERY OF ORTHOGONAL IL-2
#14NON-NATURAL NKG2D RECEPTORS THAT DO NOT DIRECTLY SIGNAL THE CELLS TO WHICH THEY ARE ATTACHED
#15BISPECIFIC NK CELL AGONIST, PREPARATION METHOD, AND APPLICATION
#16PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1
#17ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF
#18Compositions and Methods for Treating Cancer with DuoCARs
#19COMPOSITIONS AND METHODS FOR TREATING CANCER WITH DUOCARS
#20FUSIONS OF MUTANT INTERLEUKIN-10 POLYPEPTIDES WITH ANTIGEN BINDING MOLECULES FOR MODULATING IMMUNE CELL FUNCTION
#21ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF
#22IL-2R-BETA-GAMMA BINDING COMPOUNDS
#23ARTIFICIAL SYNAPSES
#24BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF
#25Transferrin Receptor Binding Protein
#26Fusion molecules and IL-15 variants
#27COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION
#28Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety
#29Methods to spatially profile protease activity in tissue and sections
#30MODIFIED CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#31BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3
#32Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
#33Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#34FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15Ra AND THERAPEUTIC USES THEREOF
#35MULTISPECIFIC AND MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#36Compositions and Methods for Treating Cancer with DuoCARs
#37Fusion molecules and IL-15 variants
#38Recombinant vector for expressing target protein in plant cell
#39PROTEINACEOUS HETERODIMER AND USE THEREOF
#40Compositions and Methods for Treating Cancer with DuoCARs
#41Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
#42COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES
#43SYSTEMS AND METHODS FOR COMPARTMENT SPATIAL ORGANIZATION
#44DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE
#45NEW IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
#46Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
#47METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS
#48Extracellular vesicles comprising engineered fusion proteins
#49Artificial synapses
#50IL-2R-βγ binding compounds
#51FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15Ra AND THERAPEUTIC USES THEREOF
#52Targeted immunotolerance
#53VECTOR CO-EXPRESSING VACCINE AND COSTIMULATORY MOLECULES
#54Compositions and methods for treating cancer with DuoCARs
#55Recombinant vector for expressing target protein in plant cell
#56FGFR3 binding molecules
#57COSTIMULATORY CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING IL13R-alpha-2
#58Immunocytokines for the treatment of cancer
#59Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#60Compositions and methods for treating cancer with DuoCARs
#61IL-11Rα antibodies
#62Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5
#63IL-11 antibodies
#64Interleukin 15 (IL-15) variants
#65Non-natural NKG2D receptors that do not directly signal the cells to which they are attached
#66Compositions, methods, and systems for affinity-based protein identification and purification
#67Multivalent regulatory T cell modulators
#68Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use
#69Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use
#70IL2 and TNF immunoconjugates
#71Compositions and methods for treating cancer with DuoCARs
#72Targeted Therapeutic Proteins
#73Modified cell expansion and uses thereof
#74TRI-AGONIST FOR THE GLu, GLP-1 AND NPY2 RECEPTORS
#75Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
#76Bi-functional chimeric proteins and uses thereof
#77Modified chimeric antigen receptors and methods of use
#78Method for producing TLR5 agonist protein
#79Compositions and methods for treating cancer with DuoCARs
#80REDIRECTING IMMUNE RESPONSES
#81Vector co-expressing vaccine and costimulatory molecules
#82Long-acting recombinant follicle-stimulating hormone and use thereof
#83Vector co-expressing vaccine and costimulatory molecules
#84Targeted immunotolerance
#85Methods to spatially profile protease activity in tissue and sections
#86Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases
#87Bispecific antibodies specifically binding to PD1 and LAG3
#88FGFR3 binding molecules
#89Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#90Targeted immunotolerance
#91Recombinant vectors comprising 2A peptide
#92Tumor infiltrating lymphocytes for treatment of cancer
#93Immunity enhancing agent for cancer by Allergin-1 antagonist
#94Fusion molecule based on TAA variant
#95ALBUMIN FUSION PROTEINS
#96Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases
#97Multivalent regulatory T cell modulators
#98GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME
#99Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#100IL2 and TNF immunoconjugates
#101Targeted therapeutic proteins
#102Fusion proteins comprising a binding protein and an interleukin-15 polypeptide having a reduced affinity for IL15Ra and therapeutic uses thereof
#103Method of preparing an anti-serum albumin Fab-effector moiety fusion construct
#104MET receptor agonist proteins
#105Multispecific and multifunctional molecules and uses thereof
#106Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains
#107Method of highly expressing target protein from plant using RbcS fusion protein and method of preparing composition for oral administration of medical protein using target protein expression plant body
#108CHIMERIC PROTEIN
#109Cytokine-based fusion proteins for treatment of immune disorders
#110MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS
#111T-cell redirecting bispecific antibodies for treatment of disease
#112FGF23 c-tail fusion proteins
#113Anti-FGFR1c antibody-FGF21 fusion proteins
#114Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins
#115Fusion molecule based on novel TAA variant
#116Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
#117LONG-ACTING OXYNTOMODULIN VARIANTS AND METHODS OF PRODUCING SAME
#118Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
#119T-cell redirecting bispecific antibodies for treatment of disease
#120Anti-serum albumin Fab-effector moiety fusion construct, and a method of preparing the construct
#121IL-15 variants and uses thereof
#122Modified microbial toxin receptor for delivering agents into cells
#123Costimulatory chimeric antigen receptor T cells targeting IL13Rα2
#124G-PROTEIN COUPLED RECEPTOR AGONISTS AND METHODS
#125Vector co-expressing vaccine and costimulatory molecules
#126Epitope Spreading Associated with CAR T-Cells
#127T-cell redirecting bispecific antibodies for treatment of disease
#128Targeted therapeutic proteins
#129Vault complexes
#130MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS
#131Polypeptide hydrogels and uses related thereto
#132Methods of treating disease with fusion molecules comprising IL-15 variants
#133Cytokine-based fusion proteins for treatment of immune disorders
#134Deletion mutants of flagellin and methods of use
#135Deletion mutants of flagellin and methods of use
#136Long-acting oxyntomodulin variants and methods of producing same
#137Chimeric molecule involving oligomerized FasL extracellular domain
#138Bifunctional peptide
#139Thrombopoietic compounds
#140Rationally designed antibodies
#141Growth hormone polypeptides and methods of making and using same
#142Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
#143Fusion molecules and IL-15 variants
#144Relaxin fusion polypeptides and uses thereof
#145Targeted therapeutic proteins
#146Treatment with factor ix-albumin fusion protein
#147Treatment with factor VII-albumin fusion protein
#148Albumin Fusion Proteins
#149VEGF-activated trail ligands
#150Anticancer fusion protein comprising TRAIL and interferon
#151Fusion molecule based on novel TAA variant
#152Human FGF receptor and β-Klotho binding proteins
#153Reducing the immunogenicity of fusion proteins
#154Targeted therapeutic proteins
#155Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#156FGF21 conjugates and anti-diabetic uses thereof
#157ALBUMIN FUSION PROTEINS
#158Therapeutic Compositions For The Treatment of HPV-Induced Diseases
#159Fusion molecules and IL-15 variants
#160Thrombopoietic compounds
#161IGF-1 fusion polypeptides and therapeutic uses thereof
#162Targeted therapeutic proteins
#163Albumin fusion proteins
#164Albumin Fusion Proteins
#165Modified TGF-β superfamily protein
#166Thrombopoietic compounds
#167Humanized GM-CSF antibodies
#168EXPRESSION VECTORS ABLE TO ELICIT IMPROVED IMMUNE RESPONSE AND METHODS OF USING SAME
#169Albumin Fusion Proteins
#170Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#171Method for treating atherosclerosis by administering human MCP1 fusions
#172Vault complexes for facilitating biomolecule delivery
#173Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
#174Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klotho
#175Deletion mutants of flagellin and methods of use
#176LEPTIN FUSION PROTEINS
#177Growth hormone polypeptides and methods of making and using same
#178Recombinant toxin fragments
#179IGF-1 fusion polypeptides and therapeutic uses thereof
#180Combination cancer immunotherapy with co-stimulatory molecules
#181Combination cancer immunotherapy with co-stimulatory molecules
#182Targeted modification of chromatin structure
#183Expression of Human Serum Albumin in Plastids
#184Fusion molecules and IL-15 variants
#185Albumin Fusion Proteins
#186Fusion molecule based on novel TAA variant
#187Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions
#188Humanized GM-CSF antibodies
#189Targeted therapeutic proteins
#190Methods of using Fc-cytokine fusion proteins
#191Cytokine-based fusion proteins for treatment of multiple sclerosis
#192Rationally designed antibodies
#193ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#194Recombinant toxin fragments
#195Reducing the immunogenicity of fusion proteins
#196Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#197Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#198Fusion molecules and IL-15 variants
#199CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#200Albumin Fusion Proteins
#201Recombinant toxin fragments
#202Human GM-CSF antibodies
#203Recombinant toxin fragments
#204ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
#205Modified Fusion Polypeptides
#206Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same
#207Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
#208VEGF-activated ligands
#209TARGETED THERAPEUTIC PROTEINS
#210Method for producing insulin analogs having a dibasic B chain terminus
#211Thrombopoietic compounds
#212Recombinant toxin fragments
#213Methods for treating pain
#214Staphylococcal nuclease fusion proteins for the production of recombinant peptides
#215Method of increasing muscle mass with IGF-1 fusion polypeptides
#216Method for targeting lysosomal enzymes
#217Targeted modification of chromatin structure
#218PEPTIDES
#219Albumin Fusion Proteins
#220Albumin Fusion Proteins
#221Albumin Fusion Proteins
#222Albumin fusion proteins
#223Albumin Fusion Proteins
#224Albumin Fusion Proteins
#225Nerve cell growth modulators (amphibodies)
#226Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album
#227Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
#228HER-2/neu fusion proteins
#229DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#230Albumin fusion proteins
#231Process for production of a recombinant protein and a fusion protein
#232Modified human granulocyte-colony stimulating factor and process for producing same
#233Fusion protein suitable for high efficiency expression and the production method thereof
#234ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES
#235Albumin fusion proteins
#236Novel Therapeutic Fusion Proteins
#237Fusion Proteins
#238Recombinant toxin fragments
#239Conformational and topological protein regulation
#240FGF-21 fusion proteins
#241Compositions comprising conditioned cell culture media and uses thereof
#242Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#243Recombinant toxin fragments
#244Thrombopoietic compounds
#245MCP1 fusions
#246Latent fusion protein
#247Expression and export of angiogenesis inhibitors as immunofusins
#248Chimeric IL-10
#249Enduring T cell response
#250Homogeneity and secretion of recombinant proteins in mammalian systems
#251Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants
#252Thrombopoietic compounds
#253Targeted modification of chromatin structure
#254Stress proteins and uses therefor
#255Stress proteins and uses therefor
#256Staphylococcal nuclease fusion proteins for the production of recombinant peptides
#257Combination cancer immunotherapy with co-stimulatory molecules
#258IGF-I fusion polypeptides and therapeutic uses thereof
#259Chimeric protein
#260Enrichment method for variant proteins with altered binding properties
#261Recombinant toxin fragments
#262Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions
#263Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#264Fusion proteins of humanized g250 specific antibodies and uses thereof
#265Transgenically produced fusion proteins
#266Reducing the immunogenicity of fusion proteins
#267Enhanced secretion of a polypeptide by a microorganism
#268Conformational and topological protein regulation
#269Methods for treating pain
#270Erythropoietin with high specific activity
#271Targeted therapeutic proteins
#272Albumin fusion proteins
#273Albumin fusion proteins
#274Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
#275Modified TGF-beta superfamily proteins
#276Recombinant toxin fragments
#277Enhanced secretion of a polypeptide by a microorganism
#278Production of proteins
#279Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
#280Enhanced secretion of a polypeptide by a microorganism
#281Stress proteins and uses therefor
#282Enhanced secretion of a polypeptide by a microorganism
#283Modified growth hormone fusion polypeptides
#284Enhanced secretion of a polypeptide by a microorganism
#285Identification of human cell lines for the production of human proteins by endogenous gene activation
#286Thrombopoietic compounds
#287Chimeric IL-10 proteins and uses thereof
#288Albumin fusion proteins
#289Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
#290Method for extracellular production of target proteins employing OmpF in
#291Peptides
#292Conformational and topological protein regulation
#293Conformational and topological protein regulation
#294Conformational and topological protein regulation
#295Fusion molecules and IL-15 variants
#296Compositions and methods for the treatment of trail-resistant cancer